Quantcast

Latest Anorectics Stories

2014-10-14 16:28:02

North Carolina technical assistant wins a free space makeover PHILADELPHIA, Oct. 14, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced the winners of the Organize Your Stuff contest, which was designed to help adults organize their space and reduce clutter. Sydney Bloom, 28, from Charlotte, NC was chosen as the grand prize winner after submitting a picture of her craft room and the reason she needed help organizing it. To help Sydney achieve her organizational goals,...

2014-10-06 12:29:08

TORONTO, Oct. 6, 2014 /PRNewswire/ - Highland Therapeutics Inc. ("Highland"), today announced that Phase II data generated by the Company's principal operating subsidiary, Ironshore Pharmaceuticals & Development, Inc. ("Ironshore"), will be presented at the American Academy of Child & Adolescent Psychiatry (AACAP) Annual Meeting, which is being held October 20(th) to 25(th) in San Diego, CA. Data from the HLD-200 (methylphenidate) Phase II study, The Single Dose...

2014-10-06 08:28:52

18-MC Well Tolerated by Subjects in Development Partner's Study SAN CARLOS, Calif., Oct. 6, 2014 /PRNewswire/ -- Savant HWP, Inc., a privately held drug development company, confirmed the initiation of human safety testing of 18-MC, an experimental treatment for many forms of addiction. A single dose of 18-MC, administered as part of a double-blind, placebo-controlled human safety study conducted by Savant's South American partner, was well tolerated by healthy volunteers receiving...

2014-09-24 23:02:01

The Firm is evaluating Byetta lawsuits and other product liability claims that allege incretin mimetic diabetes drugs caused patients to develop pancreatic cancer, pancreatitis and thyroid cancer. New York, New York (PRWEB) September 24, 2014 Byetta lawsuits(http://www.byettalawsuit.com) and other product liability claims that allege incretin mimetic Type 2 diabetes medications caused patients to develop pancreatic cancer continue to move forward in U.S. courts, Bernstein Liebhard LLP...

2014-09-23 08:30:46

18-MC Well Tolerated by Subjects in Development Partner's Study SAN CARLOS, Calif., Sept. 23, 2014 /PRNewswire/ -- Savant HWP, Inc., a privately held drug development company, today confirmed the initiation of human safety testing of 18-MC, an experimental treatment for many forms of addiction. A single dose of 18-MC, administered as part of a double-blind, placebo-controlled human safety study conducted by Savant's South American partner, was well tolerated by healthy volunteers...

2014-09-17 08:29:46

- Data indicate 58% non-adherence to second-line treatments in T2D patients, significantly higher than patients report and prescribers perceive VIENNA, Sept. 17, 2014 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the presentation of compelling, quantitative data from a study of the cost and predictability of non-adherence in type 2 diabetes therapies at the 50(th) Annual Meeting of the European Association for the Study of Diabetes (EASD). In a poster session today, Christian...

2014-09-15 08:29:16

PHILADELPHIA, September 15, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has accepted for filing with priority review a supplemental New Drug Application (sNDA) for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) as a treatment for adults with binge eating disorder (BED). The FDA is expected to provide a decision in February 2015, based on the...

contrave
2014-09-12 05:31:01

John Hopton for redOrbit.com - Your Universe Online The Food and Drug Administration (FDA) has approved the weight loss pill Contrave, a medication that will be used to treat obese adults in conjunction with a controlled diet and exercise. It is the third such drug to be approved since 2012, although its predecessors have not sold well and all have considerable potential side effects. An FDA statement advises that Contrave, which works by decreasing appetite, is approved for use in...

2014-09-11 16:27:32

Colorado and Washington experience surges in marijuana tests positivity rate, but data suggests state legalization of recreational marijuana may not be sole driver of increases MADISON, N.J., Sept. 11, 2014 /PRNewswire/ -- The percentage of positive drug tests among American workers has increased for the first time in more than a decade, fueled by a rise in marijuana and amphetamines, according to an analysis of 8.5 million urine, oral fluid and hair workplace drug test results...

2014-09-11 08:27:41

New Medication for Obese Adults, or Overweight Adults with at Least One Weight-Related Comorbid Condition DEERFIELD, Ill., and LA JOLLA, Calif., Sept. 11, 2014 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. (Nasdaq: OREX) jointly announced today that the U.S. Food and Drug Administration (FDA) has approved Contrave® (naltrexone HCI and bupropion HCI) extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for...


Word of the Day
bellycheer
  • Good cheer; viands.
  • To revel; to feast.
The word 'bellycheer' may come from 'belle cheer', "good cheer".
Related